Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study
Nutrients · 2025
DOI: 10.3390/nu17111783 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nutrients, 2025. Verfasst von Yixing Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Multimorbidity, Cardiovascular Diseases, Renal Insufficiency, Chronic, Aging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Program of Natural Science Fund of China, Capital's Funds for Health Improvement and Research, Program of Natural Science Fund of China.
Abstract (Originalsprache)
Objectives
Previous studies have confirmed that biological age (BA) acceleration is associated with single cardio-renal–metabolic diseases (CRMDs), typically including type 2 diabetes mellitus, cardiovascular disease, and chronic kidney disease. However, its association with progression to cardio-renal–metabolic multimorbidity (CRMM, coexistence of ≥2 CRMDs) and subsequent mortality remains unexplored.
Methods
Using the multi-state model, we analyzed 278,927 UK Biobank participants free of CRMDs at baseline to investigate the association between BA acceleration—measured by phenotypic age (PhenoAge) and Klemera–Doubal method age (KDMAge)—and CRMM progression trajectory, from health to the first CRMD and then to CRMM and death. BA acceleration was the residual from regressing BA on chronological age; positive values indicated a biologically older individual.
Results
PhenoAge acceleration showed stronger associations than KDMAge acceleration. Per the 1-SD increase in PhenoAge acceleration; HRs (95% CIs) were observed at 1.18 (1.17–1.19) for baseline to first CRMD; 1.24 (1.22–1.26) for first CRMD to CRMM; 1.25 (1.22–1.27) for baseline to death; 1.13 (1.11–1.15) for first CRMD to death; and 1.09 (1.06–1.12) for CRMM to death. Biologically older individuals by PhenoAge acceleration showed greater reductions in CRMD-free and total life expectancy than those by KDMAge acceleration. Age, socioeconomic status, education, smoking status, alcohol consumption, physical activity, and diet-modified risks for specific transitions.
Conclusions
BA acceleration, particularly PhenoAge acceleration, relates to higher CRMM progression risk and shorter life expectancy. Combining BA acceleration with sociodemographic or lifestyle factors improves risk identification for specific transitions. BA acceleration offers the potential to guide CRMM prevention across its entire progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing 100069, China.
- Department of Mathematics and Statistics, La Trobe University, Melbourne 3086, Australia.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA.
- National Institute for Data Science in Health and Medicine, Capital Medical University, Beijing 100069, China.
- School of Medical and Health Sciences, Edith Cowan University, Perth 6027, Australia.
- Beijing Key Laboratory of Environment and Aging, Capital Medical University, Beijing 100069, China.
ORCID-Profile: Yixing Tian, Lixin Tao, Xiuhua Guo
Förderung
- The Program of Natural Science Fund of China
- Capital's Funds for Health Improvement and Research
- Program of Natural Science Fund of China
- Capital’s Funds for Health Improvement and Research
Zitieren
APA
Tian, Y., Wang, J., Zhu, T., Li, X., Zhang, H., Zhao, X., Yang, X., Luo, Y., Tao, L., Wu, Z., & Guo, X. (2025). Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study. Nutrients. https://doi.org/10.3390/nu17111783
Vancouver
Tian Y, Wang J, Zhu T, Li X, Zhang H, Zhao X, et al. Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study. Nutrients. 2025. doi:10.3390/nu17111783
BibTeX
@article{Tian2025,
author = {Tian, Yixing and Wang, Jinqi and Zhu, Tianyu and Li, Xia and Zhang, Haiping and Zhao, Xiaoyu and Yang, Xinghua and Luo, Yanxia and Tao, Lixin and Wu, Zhiyuan and Guo, Xiuhua},
title = {Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17111783}
}
EUVIMED